Skip to content
healthcare.dev

lisinopril

NDC 76282-420, lisinopril, tablet, from Exelan Pharmaceuticals Inc..

Product NDC
76282-420
Status
Listed
Labeler
Exelan Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203508
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76282-420 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISINOPRIL20 mg/1

Pharmacologic classes

Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]

Package NDCNDC-11Package
76282-420-0176282042001100 TABLET in 1 BOTTLE (76282-420-01)
76282-420-0576282042005500 TABLET in 1 BOTTLE (76282-420-05)
76282-420-10762820420101000 TABLET in 1 BOTTLE (76282-420-10)
76282-420-1876282042018180 TABLET in 1 BOTTLE (76282-420-18)
76282-420-307628204203030 TABLET in 1 BOTTLE (76282-420-30)
76282-420-457628204204545 TABLET in 1 BOTTLE (76282-420-45)
76282-420-50762820420505000 TABLET in 1 BOTTLE (76282-420-50)
76282-420-907628204209090 TABLET in 1 BOTTLE (76282-420-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1bc69836-a659-4e3b-84a7-a00b7c4dc268
  • NADAC price for package 76282042001

    GET /v1/drugs/nadac/76282042001
  • NADAC price for package 76282042010

    GET /v1/drugs/nadac/76282042010
  • NADAC price for package 76282042018

    GET /v1/drugs/nadac/76282042018
  • NADAC price for package 76282042045

    GET /v1/drugs/nadac/76282042045
  • NADAC price for package 76282042050

    GET /v1/drugs/nadac/76282042050
  • NADAC price for package 76282042090

    GET /v1/drugs/nadac/76282042090

Use it

Look up 76282-420 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76282-420 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76282-420. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.